Clinical Trial Update: Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating autologous bone marrow-derived mesenchymal stem cells for treating Amyotrophic Lateral Sclerosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Autologous bone marrow mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University of Warmia and Mazury | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: UNKNOWN